Donald Trump has informed generic drug manufacturers that they must produce their medications within the United States by August 2028 or face steep import tariffs of up to 200%.
Under the phased timeline outlined by Trump, all generic drugs imported into the U.S. will maintain a zero percent tariff for a two-year period beginning August 1, 2026. Following this initial grace period, the tariff will increase to 100% for a one-year period before rising to 200% thereafter.
In-depth summary · AI, neutral